Osaic Holdings’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
SCM
BGI
JT
OCA
PA
RCM
Osaic Holdings's PALI Position: Q2 2026 in Review
Osaic Holdings reduced its Palisade Bio (PALI) stake by 97% in Q2 2026, selling an estimated $3.94K and leaving 66 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #7812.
Osaic Holdings first reported a position in PALI in Q1 2022 and has held it in 10 quarters since. The position peaked at $4K in Q1 2022. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.
- Osaic Holdings held 66 shares of Palisade Bio worth $137 as of Q2 2026.
- Osaic Holdings sold 2,000 Palisade Bio shares in Q2 2026, an estimated $3.94K.
- Palisade Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7812 holding.
- Osaic Holdings first reported a position in Palisade Bio in Q1 2022 and has held it in 10 quarters since.
- Osaic Holdings's Palisade Bio position peaked at $4K in Q1 2022.
- 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.